The FTC is not anti-direct selling. It’s pro-truth in advertising.
The DSA misses the mark.
Del Toro et al. v. Crown Laboratories, Inc.
24-cv-573, C.D. Cal.
(March 2024)
Flores et al. v. Crown Laboratories, Inc.
24-cv-211, W.D. Mo.
(March 2024)
PanOxyl acne products
Misleadingly marketing products as safe when they contain, or are at risk of containing, the carcinogen benzene
Pending
The DSA misses the mark.
TINA.org reader takes issue with this product’s deceptive packaging.
Don’t let this company blindside you with its deceptive pricing.
Lawsuit pokes holes in company’s Swiss branding.
Why are these airport vendors slyly charging consumers for “employee benefits”?